A proof of concept for structure-based vaccine design targeting RSV in humans
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A proof of concept for structure-based vaccine design targeting RSV in humans
Authors
Keywords
-
Journal
SCIENCE
Volume 365, Issue 6452, Pages 505-509
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-08-02
DOI
10.1126/science.aav9033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation
- (2018) Eileen Goodwin et al. IMMUNITY
- The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
- (2018) Natalie I Mazur et al. LANCET INFECTIOUS DISEASES
- Discovery of a Prefusion Respiratory Syncytial Virus F-Specific Monoclonal Antibody That Provides Greater In Vivo Protection than the Murine Precursor of Palivizumab
- (2017) Min Zhao et al. JOURNAL OF VIROLOGY
- A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age
- (2017) Allison August et al. VACCINE
- Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein
- (2017) Daiyin Tian et al. Nature Communications
- Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state
- (2017) Iebe Rossey et al. Nature Communications
- Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults
- (2017) Louis Fries et al. Immunity & Ageing
- A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein
- (2017) Jarrod J. Mousa et al. Nature Microbiology
- Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus
- (2017) Xiaolin Wen et al. Nature Microbiology
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
- (2016) M Gordon Joyce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein
- (2016) Jarrod J. Mousa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
- (2016) M Gordon Joyce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus
- (2015) Maximillian S. Habibi et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- (2015) Joan O. Ngwuta et al. Science Translational Medicine
- Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
- (2015) Morgan S. A. Gilman et al. PLoS Pathogens
- Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
- (2013) J. S. McLellan et al. SCIENCE
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
- (2012) M. Magro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
- (2011) J. S. McLellan et al. JOURNAL OF VIROLOGY
- Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
- (2011) K. A. Swanson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started